Burrage Capital Management LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
Burrage Capital Management LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2021$169,000
-97.5%
2,164
-97.0%
0.17%
-96.9%
Q1 2021$6,826,000
-22.7%
72,164
-0.4%
5.53%
-17.8%
Q4 2020$8,832,000
+29.4%
72,484
-7.2%
6.73%
+25.0%
Q3 2020$6,824,000
+36.9%
78,118
+1.2%
5.39%
+54.4%
Q2 2020$4,985,000
+53.4%
77,1720.0%3.49%
+9.1%
Q1 2020$3,250,00077,1723.20%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q1 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders